Impact of Baseline Lung Function on Future Exacerbations in Patients with Moderate-to-Severe Asthma
J Asthma Allergy
.
2022 Nov 11:15:1639-1644.
doi: 10.2147/JAA.S375134.
eCollection 2022.
Authors
Asif H Khan
#
1
,
Cori Gray
#
2
,
Laurent Eckert
1
,
Caroline Amand
1
,
Jaman Maroni
3
,
Zhixiao Wang
3
,
Bethan Jones
4
,
Thomas Berni
4
,
Christopher Ll Morgan
4
,
Paul J Rowe
5
Affiliations
1
Sanofi, Chilly-Mazarin, France.
2
Sanofi, Cambridge, MA, USA.
3
Regeneron Pharmaceuticals Inc, Tarrytown, NY, USA.
4
Pharmatelligence, Cardiff, UK.
5
Sanofi, Bridgewater, NJ, USA.
#
Contributed equally.
PMID:
36387838
PMCID:
PMC9664925
DOI:
10.2147/JAA.S375134
No abstract available
Grants and funding
The study was funded by Sanofi and Regeneron Pharmaceuticals Inc.